Visit the AHRP blog:
http://ahrp.blogspot.com
Research Integrity: Bias and Fraud
The Damaging Impact of PDUFA and Why It Should be Repealed PDF Print E-mail
Tuesday, 20 March 2007
The re-prioritization of rapid approvals occurred at the expense of drug safety standards,
Read more...
 
Role of Litigation in Defining Drug Risks_JAMA / BMJ PDF Print E-mail
Monday, 22 January 2007
Documents uncovered during the course of litigation shed light on real risks of drug-induced harm that would not otherwise be known.
Read more...
 
Critique of FDA's latest SSRI Data Analysis PDF Print E-mail
Monday, 11 December 2006

PRESS BRIEFING: Critique of FDA Report: “Clinical review relationship between antidepressant drugs and suicidality in adults, 2006”    http://www.fda.gov/ohrms/dockets/ac/06/briefing/2006-4272b1-index.htm

Read more...
 
New Schizophrenia Drugs No Better Than CheaperGenerics_Bloomberg_WashPost PDF Print E-mail
Friday, 01 December 2006
U.S. State Attorneys General should investigate the fraudulent marketing of the atypical neuroleptic drugs-and FDA's role in helping conceal the truth.
Read more...
 
Negative Research Results--Mostly Concealed in Journals_SharonBegley, WSJ PDF Print E-mail
Sunday, 26 November 2006
"Why are scientists coy about publishing negative data?
Read more...
 
(C) 2008 Alliance for Human Research Protection
CMS installation and website development by Anne Krauss

General Terms & Disclaimer:

This site is not a monologue of truth. It is a catalyst for public debate about medical research conduct. The reader is urged to confront officials to clarify issues mentioned herein. This site is designed strictly to provide information for critical, literary, academic an public usage. A qualified and trustworthy medical professional must be consulted regarding medical issues, treatments, diagnoses, etc.

Please read the General Terms and Conditions of this agreement entirely and carefully before accessing this web site. By accessing the site, you agree to be bound by the terms and conditions listed herein. [continue]